In conclusion, IFIT3 promotes LNM in ESCC through the LASP1/FAK/ERK axis, and IFIT3 is a potential therapeutic target for LNM in ESCC. The gene discussed is IFIT3; the disease is esophageal squamous cell carcinoma.